Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 429P7 | — |
patient was possible given diluent only instead of reconstituted vaccine; patient was possible given diluent only instead of reconstituted vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 63-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 429P7) for prophylaxis. On 31-JUL-2025, the patient received Arexvy. On 31-JUL-2025, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient was possible given diluent only instead of reconstituted vaccine) and inappropriate dose of vaccine administered (Verbatim: patient was possible given diluent only instead of reconstituted vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-SEP-2025 Pharmacist explained that a patient was possible given diluent only instead of reconstituted vaccine of Arexvy.